ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,093 | -98.4% | 1,150 | -98.0% | 0.00% | -100.0% |
| Q2 2022 | $67,380 | +96.7% | 56,150 | +114.7% | 0.00% | +200.0% |
| Q1 2022 | $34,257 | +216.5% | 26,150 | +325.2% | 0.00% | – |
| Q4 2021 | $10,824 | +221.8% | 6,150 | +296.8% | 0.00% | – |
| Q3 2021 | $3,364 | -38.0% | 1,550 | 0.0% | 0.00% | – |
| Q2 2021 | $5,425 | -60.7% | 1,550 | +10.7% | 0.00% | -100.0% |
| Q1 2021 | $13,804 | -17.8% | 1,400 | -9.7% | 0.00% | 0.0% |
| Q4 2020 | $16,802 | +5.2% | 1,550 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $15,965 | +282.3% | 1,550 | +675.0% | 0.00% | – |
| Q2 2020 | $4,176 | +113.7% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $1,954 | -15.2% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $2,304 | +111.4% | 200 | 0.0% | 0.00% | – |
| Q3 2019 | $1,090 | -54.2% | 200 | 0.0% | 0.00% | – |
| Q2 2019 | $2,378 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |